Search

Your search keyword '"Shomali, Navid"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Shomali, Navid" Remove constraint Author: "Shomali, Navid" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
27 results on '"Shomali, Navid"'

Search Results

3. Association of the matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of coronavirus disease 2019 (COVID-19); implications of contribution for development of neurological symptoms in the COVID-19 patients

4. Correction: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)

6. A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review

7. Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach

8. Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects

9. Correction: Anastasis: cell recovery mechanisms and potential role in cancer

10. Correction to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)

11. Anastasis: cell recovery mechanisms and potential role in cancer

12. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)

14. Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction

15. Cancer combination therapies by angiogenesis inhibitors; a comprehensive review

16. Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons

17. Hurdles to breakthrough in CAR T cell therapy of solid tumors

19. Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients

20. Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism

21. Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism

22. Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy

23. CAR T cells in solid tumors: challenges and opportunities

24. Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease

Catalog

Books, media, physical & digital resources